Popdc2 is a member of the POP family of proteins containing three putative transmembrane domains. It is a membrane-associated protein with the Popeye domain located in the cytoplasmic portion. This domain displays limited sequence homology to other proteins, while sequence conservation amongst Popeye proteins is high, amounting to approximately 40%–60% . The protein structure includes a cAMP binding region that shares structural similarity with other cAMP-binding domains found in eukaryotic protein kinase A (PKA) and HCN channels .
Popdc2 functions as a cAMP effector protein in cellular systems . It binds cyclic nucleotides with a binding affinity (IC50) for cAMP of 120 nM, which is comparable to the affinities reported for PKA (100 nM) and HCN4 (240 nM) . This interaction regulates various downstream cellular processes, particularly in striated muscle tissue. One of the key interacting proteins is the two-pore potassium (K2P) channel TREK-1, where Popdc2 enhances TREK-1 current by increasing its membrane representation, suggesting a role in modulating ion channel trafficking .
Popdc2 is predominantly expressed in skeletal and cardiac muscle tissues . In zebrafish embryonic development, Popdc2 transcripts are detected in the embryonic myocardium and transiently in the craniofacial and tail musculature . This expression pattern aligns with its functional role in these tissues and explains why defects in Popdc2 primarily affect cardiac and skeletal muscle development and function.
Popdc2 shows remarkable evolutionary conservation across vertebrate species. The gene has been identified in humans, mice, rats, horses, domestic cats, dogs, chickens, zebrafish, naked mole-rats, domestic guinea pigs, sheep, and cows . The high degree of conservation suggests the fundamental importance of this protein in vertebrate physiology, particularly in muscle tissue development and function.
Standard methods for studying Popdc2 gene expression include RT-PCR analysis using gene-specific primers. For zebrafish studies, primers such as zf-popdc2-fw (5′-GACGGGGAACAGAAGCACAGACA-3′) and zf-popdc2-rev (5′-ACCGCCCATATAGCCCAGAAAAA-3′) have been used effectively . In situ hybridization can also be employed to analyze spatial expression patterns during development. For protein-level analysis, immunohistochemistry with specific antibodies against Popdc2 is commonly used to visualize its cellular and subcellular localization in tissue sections.
For Popdc2 knockdown studies in zebrafish, morpholino oligonucleotides targeted to splice donor and acceptor sequences have proven effective. Specifically, morpholinos targeting the splice donor (MO2) and acceptor sequences (MO1) of intron 1 have been used successfully to suppress expression of the popdc2 transcript . These can be used singly or in combination. Validation of knockdown efficiency should include RT-PCR analysis to detect aberrantly spliced transcripts. For rescue experiments, mouse Popdc2 cRNA (approximately 100 pg) can be co-injected with morpholinos (1 ng of MO1-popdc2) to confirm phenotype specificity .
Recombinant mouse Popdc2 protein can be produced using bacterial or mammalian expression systems. For bacterial expression, the protein sequence from Ser2-Lys255 with an N-terminal His tag has been successfully used . The recombinant protein can be purified using affinity chromatography with nickel columns for His-tagged proteins. For functional studies, it's important to ensure proper folding of the protein, particularly the Popeye domain, which is crucial for cAMP binding. Mammalian expression systems may provide better post-translational modifications and protein folding compared to bacterial systems.
Appropriate controls for Popdc2 functional studies include:
Using control morpholinos with similar chemical properties but no target in the organism for knockdown studies
Rescue experiments using wild-type Popdc2 cRNA to confirm phenotype specificity
Including both positive controls (tissues known to express Popdc2) and negative controls (tissues not expressing Popdc2) for expression studies
When studying cAMP binding, comparing with other known cAMP-binding proteins like PKA as reference standards
For interaction studies, including both positive interacting proteins (e.g., TREK-1) and non-interacting proteins as controls
Popdc2 functions as a novel class of cAMP effector protein . The Popeye domain binds cyclic nucleotides with an affinity comparable to other well-established cAMP-binding proteins. The closest related non-Popdc proteins are bacterial CAP or CRP proteins, which function as cyclic nucleotide-regulated transcription factors . Popdc2 interacts with other components of the cAMP signaling pathway, including phosphodiesterase 4 (PDE4) and adenylyl cyclase 9 (AC9) . These interactions suggest that Popdc2 may serve as a crucial mediator between cAMP signaling and downstream cellular processes, particularly in muscle tissues.
In Popdc2 knockout mice, a stress-induced sinus node bradycardia is observed, which is strictly stress-dependent. At rest, a normal ECG is observed . In zebrafish popdc2 morphants, more severe phenotypes are observed:
Aberrant development of skeletal muscle, with irregularly shaped muscle segments in the trunk
Severely reduced or missing craniofacial muscles
Pericardial edema and elongated heart chambers with abnormal looping
Cardiac arrhythmia, with irregular ventricular contractions showing a 2:1 or 3:1 atrial/ventricular conduction ratio
These phenotypes highlight Popdc2's crucial role in both cardiac and skeletal muscle development and function.
Popdc2 has been demonstrated to interact with the two-pore potassium (K2P) channel TREK-1. In the presence of Popdc proteins, TREK-1 current is increased due to enhanced membrane representation of the channel, suggesting a role for Popdc2 in modulating ion channel trafficking . The cardiac arrhythmia observed in popdc2 morphants resembles the phenotype of the breakdance mutant in zebrafish, which is defective in the Kcnh2 potassium channel involved in cardiac repolarization . This suggests that Popdc2 may play a role in cardiac repolarization, possibly through interactions with potassium channels.
Mutations in Popdc2 can affect its interactions with partner proteins, including other members of the Popdc family and ion channels. The ability of Popdc2 to form heteromeric complexes is critical for its function in muscle and cardiac tissues. Mutations may disrupt protein-protein interactions, cAMP binding capacity, or subcellular localization, leading to dysfunction in cardiac conduction and muscle development . Specific experimental approaches to study these heteromeric interactions include co-immunoprecipitation, yeast two-hybrid assays, and fluorescence resonance energy transfer (FRET) techniques.
Studying Popdc2's role in cardiac conduction presents several methodological challenges:
The stress-dependent nature of arrhythmias in Popdc2-deficient models requires specialized protocols to induce and record cardiac stress responses
Distinguishing between primary conduction defects and secondary effects from structural abnormalities requires sophisticated electrophysiological techniques
The relationship between Popdc2 and other cardiac ion channels necessitates complex interaction studies
In vivo cardiac imaging in small animal models requires high spatiotemporal resolution techniques
Researchers have addressed these challenges using optical recordings of cardiac contractility and calcium transients with high spatiotemporal resolution, such as employing transgenic calcium indicator lines (e.g., Tg(cmlc2:gCaMP)s878) and SPIM microscopy .
To effectively analyze Popdc2's dual role in cardiac and skeletal muscle development, researchers should employ a multi-faceted approach:
Tissue-specific conditional knockout models to separate cardiac and skeletal muscle functions
Time-course analysis of gene expression during embryonic development to identify critical windows for each tissue
Combining morphological assessment with functional studies:
For cardiac function: ECG recordings, optical mapping, calcium imaging
For skeletal muscle: phalloidin staining, analysis of myofibrillar organization, assessment of muscle force generation
Expression of tissue-specific rescue constructs to delineate tissue-autonomous versus non-autonomous effects
Analysis of different muscle types (e.g., fast vs. slow muscle fibers) to determine fiber-type specificity
This comprehensive approach can help distinguish between the cardiac and skeletal muscle functions of Popdc2.
A number of patients carrying pathogenic variants in POPDC genes, including POPDC2, have been identified and suffer from heart and/or muscle disease . While the search results don't provide specific details about POPDC2 variants, the conservation of function between mouse and human suggests that mutations would likely affect cardiac rhythm, particularly under stress conditions, and potentially skeletal muscle development and function. Research approaches to study these variants include:
Generation of patient-specific induced pluripotent stem cells (iPSCs) and differentiation into cardiomyocytes
CRISPR-Cas9 gene editing to introduce specific variants into model systems
Electrophysiological characterization of variant effects on cardiac conduction
Protein interaction studies to assess the impact on binding partners like ion channels
The Popdc family includes Popdc1 (also known as Bves), Popdc2, and Popdc3. These proteins share structural similarities but may have distinct and overlapping functions:
Both Popdc1 and Popdc2 knockout mice display nearly identical stress-induced sinus node bradycardia, suggesting functional overlap in cardiac conduction
Popdc1 knockout mice show enhanced vulnerability to ischemia-reperfusion and impaired skeletal muscle regeneration after injury
In zebrafish, both bves (Popdc1) knockout mutants and popdc2 morphants display cardiac arrhythmia and muscular dystrophy, indicating conserved functions
All Popdc family members are expressed in muscle and heart across vertebrates, suggesting conserved tissue-specific roles
Comprehensive comparative studies of all three family members are needed to fully understand their unique and redundant functions.
Promising future research directions for translating Popdc2 research to clinical applications include:
Comprehensive cataloging of human POPDC2 variants in patients with cardiac arrhythmias and muscle disorders
Development of small molecules that can modulate Popdc2-cAMP interactions for potential therapeutic applications
Investigation of the role of Popdc2 in cardiac ischemia-reperfusion injury and potential protective strategies
Exploration of Popdc2's involvement in age-related cardiac conduction disorders
Study of interactions between Popdc2 and pharmacological agents used to treat arrhythmias
Development of tissue-specific gene therapy approaches to correct POPDC2 deficiencies
These directions could lead to novel diagnostic markers and therapeutic targets for cardiac arrhythmias and muscle disorders.
Optimal conditions for preserving Popdc2 protein activity in recombinant preparations include:
Maintaining appropriate pH (typically 7.2-7.4) and ionic strength similar to physiological conditions
Including stabilizing agents such as glycerol (10-20%) to prevent protein denaturation
Adding reducing agents (DTT or β-mercaptoethanol) to maintain cysteine residues in reduced form
Storing at -80°C for long-term storage, with minimal freeze-thaw cycles
Including protease inhibitors to prevent degradation
For functional studies involving cAMP binding, ensuring the buffer conditions support nucleotide binding
These conditions should be optimized based on the specific experimental application and the protein construct being used.
To differentiate between direct and indirect effects of Popdc2 on ion channel function, researchers can employ:
Direct binding assays: Co-immunoprecipitation, FRET, and surface plasmon resonance to demonstrate physical interaction between Popdc2 and ion channels
Reconstitution experiments: Expressing Popdc2 and ion channels in heterologous expression systems that lack endogenous Popdc proteins
Domain mapping studies: Creating chimeric or truncated Popdc2 proteins to identify specific domains required for ion channel interactions
Acute manipulation experiments: Using rapid inhibition or activation of Popdc2 to distinguish immediate (likely direct) effects from delayed (possibly indirect) effects
Pathway inhibition studies: Systematically blocking potential intermediate signaling molecules to identify indirect pathways
These approaches collectively can help establish the mechanistic basis of Popdc2's effects on ion channel function.
Recommended methods for studying cAMP binding to Popdc2 include:
Radioligand binding assays: Using [³H]-cAMP or [³²P]-cAMP to measure direct binding to purified Popdc2 protein
Fluorescence-based assays: Employing fluorescently labeled cAMP analogs and measuring changes in fluorescence upon binding
Surface plasmon resonance (SPR): Immobilizing Popdc2 on a sensor chip and measuring binding kinetics of cAMP in real-time
Isothermal titration calorimetry (ITC): Providing thermodynamic parameters of binding without requiring labels
FRET-based sensors: Creating chimeric proteins combining Popdc2 with fluorescent proteins to detect conformational changes upon cAMP binding
When designing these experiments, it's important to compare results with established cAMP-binding proteins such as PKA (IC50 ~100 nM) and HCN4 (IC50 ~240 nM) as reference standards .
While Popdc2 is predominantly studied in cardiac and skeletal muscle contexts, emerging evidence suggests broader roles that warrant investigation:
Potential involvement in smooth muscle function, particularly in vascular tissues
Possible roles in non-muscle tissues where cAMP signaling is important
Interactions with additional ion channels beyond TREK-1
Potential involvement in cellular responses to stress and hypoxia
Roles in development and regeneration outside the muscle context
These emerging areas represent important directions for future research to fully understand the biological significance of Popdc2.
Understanding Popdc2 function could contribute to developing therapies for cardiac arrhythmias through:
Identification of novel drug targets within the Popdc2-associated signaling network
Development of small molecules that modulate Popdc2-cAMP binding or Popdc2-ion channel interactions
Gene therapy approaches to correct deficient or mutant POPDC2 in patients with arrhythmias
Biomarkers for identifying patients at risk for stress-induced arrhythmias
Personalized medicine approaches based on patient-specific POPDC2 genetic variants
Improved understanding of the molecular basis of stress-dependent arrhythmias, which remain challenging to treat